Clinical utility of emerging liquid biomarkers in ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

Liquid biomarkers have high potential to be used for prognosis, monitoring treatment response and guiding treatment selection.

Clinical utility of emerging liquid biomarkers in advanced prostate ...

The development of molecular biomarkers will be key for patient stratification, and for monitoring response and resistance to therapy. In this context, ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

In this review we focus on the clinical application of novel liquid biomarkers that have the potential to monitor and stratify patients.

Clinical utility of emerging liquid biomarkers in advanced prostate ...

Circulating tumor DNA (ctDNA) and tumor cells (CTCs) inform on metastatic tumor burden. •. AR changes in ctDNA and CTCs associate with poor response to AR- ...

Clinical utility of emerging liquid biomarkers in ... - Cancer Genetics

The therapeutic landscape of advanced prostate cancer (PCa) has rapidly expanded in re- cent years. Despite significant improvements in patient overall ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

Until now, urine-derived biomarkers have proven their clinical use as diagnostic and prognostic tools. Four urinary liquid biomarker tests are ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

Areas covered In this review we focus on the clinical application of novel liquid biomarkers that have the potential to monitor and stratify ...

Assessing the Clinical Utility of Liquid Biopsies Across 5 Potential ...

This review assesses 5 clinical indications for molecular-based tests to detect and quantify tumor DNA circulating in the bloodstream among ...

Potential clinical utility of liquid biopsy in early-stage non-small cell ...

Liquid biopsy has been widely researched for early diagnosis, prognostication and disease monitoring in lung cancer, but there is a need to ...

Clinical utility of liquid biopsy-based companion diagnostics in the ...

Its clinical utility is under assessment in several clinical trials. This review introduces recent advances in liquid biopsy methodology, the ...

The Utility of Liquid Biopsies in Radiation Oncology

These promising classes of biomarkers could have an outsized impact on cancer management by meaningfully stratifying patients into risk groups, ...

Potential clinical utility of liquid biopsies in ovarian cancer

Liquid biopsy is a non-invasive method with emerging evidence for its utility in screening and longitudinal monitoring of ovarian cancer.

Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in ... - MDPI

A new, easy-to-use and non-invasive test based on liquid biopsy biomarkers such as Progensa PCA3, MyProstateScore, ExoDx, SelectMDx, PHI, 4K, Stockholm3 and ...

Clinical utility of liquid biopsy and integrative genomic profiling in ...

Many studies have shown a good correlation between tissue and liquid biopsies in advanced-stage patients [22,23,24,25,26,27]. However, in cases ...

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify ...

Guideline-complete genotyping indicates that all eight guideline-recommended biomarkers were assessed in tissue genotyping or cfDNA and a positive or negative ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

Clinical utility of emerging biomarkers in prostate cancer liquid biopsies · List of references · Publications that cite this publication.

Biomarkers in dementia: clinical utility and new directions

Biomarkers in dementias can be divided into imaging modalities, which are already widely used in clinical and research settings; and cerebrospinal fluid (CSF) ...

Clinical utility of emerging biomarkers in prostate cancer liquid ...

Clinical utility of emerging biomarkers in prostate cancer liquid biopsies. Boerrigter, E.; Groen, L.N.; Van Erp, N.P.; Verhaegh, G.W.; Schalken, J.A.. Expert ...

The Utility of Liquid Biopsies in Radiation Oncology

An emerging application of liquid biopsy is as a predictive biomarker. ... biomarkers remains an area of active research with few examples in clinical practice.

Circulating tumor DNA: current challenges for clinical utility - JCI

In summary, liquid biopsies with ctDNA are a relatively new approach to help guide clinical decision making for the prevention, diagnosis, and ...